# SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c

> **NCT00598663** · NA · COMPLETED · sponsor: **Medtronic MiniMed, Inc.** · enrollment: 153 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** insulin pump with continuous glucose sensing (Paradigm Real-Time Insulin Pump System)
- **DEVICE:** insulin pump and blinded continuous glucose sensing (Paradigm Real-Time insulin pump)

## Key facts

- **NCT ID:** NCT00598663
- **Lead sponsor:** Medtronic MiniMed, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598663, "SWITCH - Sensing With Insulin Pump Therapy to Control HbA1c". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00598663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*